Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Analog Devices

Automatic Data Processing

Booking Hlds

Gilead Sciences

Mondelez

Starbucks

While the market rally this year has been an investor's dream after the nightmare of last year, the reality is that a handful of red-hot technology stocks running higher on the back of the Artificial Intelligence explosion has created almost all of the gains in the S&P 500 and the Nasdaq.

With The Massive NASDAQ Rebalance Coming Soon 7 ‘Strong Buy' Stocks Could Explode Higher

Johnson & Johnson

Pfizer

Teladoc

Healthcare stocks stumbled in the first half as investors favored higher-growth industries. Investors piled into technology and consumer discretionary stocks.

Should You Buy the First Half's Worst-Performing Sector?

Wall Street analysts see Intuitive Surgical's shares falling soon. Its high valuation is a risk that might help analyst estimates pan out.

Wall Street Thinks Intuitive Surgical Stock Will Fall, But Investors Should Be Skeptical

Medtronic

Medtronic is going through an "aggressive transformation" to accelerate growth. In the robotic surgery market, Intuitive Surgical has a hugely dominant position.

Better Buy: Medtronic vs. Intuitive Surgical

Intuitive Surgical is a leading player in the Medical Instruments & Supplies industry, specializing in advanced robotic systems that revolutionize minimally invasive surgeries. The company has a strong track record and is expected to maintain double-digit sales growth, capitalizing on the increasing use of surgical robots in various procedures. Despite the high stock valuation, recent developments and an upgraded financial outlook make Intuitive Surgical stock an attractive investment, particularly if bought during a market correction.

Intuitive Surgical: Aggressive Wealth Compounding In Healthcare

Apple

Exxon Mobil

Intuitive Surgical's robotic systems are improving patient outcomes. ExxonMobil is quickly becoming a leader in low-carbon energy solutions.

3 Top Stocks to Buy Now and Hold Forever

UiPath

Zebra Technologies

Robotic revolution has always intrigued us, captivating our imagination since the 1950s when modern robotics took its first steps. While the idea of lifelike machines performing human tasks may evoke mixed feelings, it's crucial to understand that robotics is not about replacing humans – It's about empowering us.

3 Robotics Stocks to Make Your ‘Get Rich' Dreams Come True

We touch upon some admirable facets of the Intuitive story. We then shift attention to some unfavorable aspects of Intuitive. We close with some thoughts on the technicals.

Intuitive Surgical - Quality Business, But Unlikely To Reward New Investors At This Time

The S&P is in both the bullish end-of-month and the holiday periods of bullish bias.

Stocks This Week: Buy D.H Horton And Intuitive Surgical

iRhythm Technologies

Rockwell Automation

Teradyne

In the world of investing, the spotlight is currently on robotics stocks for high returns. The heightened attention results from continuous advancements in automation and artificial intelligence, effectively boosting demand for sophisticated robotics solutions.

7 Robotics Stocks to Target for Triple-Digit Returns in 2023

There is more to the comparison, and in the sections below, we discuss why we believe ISRG stock will offer better returns than MDT stock in the next three years.

Should You Buy Intuitive Surgical Stock Over MDT?

Cigna

Demand for Intuitive Surgical's and Cigna's products and services should grow. The two companies are each leaders of their respective industries.

Looking for Blue Chip Growth Stocks? These 2 Healthcare Stocks Have Crushed the Market

Over the next decade, the robotics industry is likely to have a big impact on economic output and productivity. Be it industrial automation, construction, mobility or healthy, robotics will provide increased efficiency and accuracy.

3 Robotics Stocks to Buy With Explosive Upside Potential

Lululemon Athletica

Shopify

Some of last year's struggling growth stocks are building momentum today. Three in particular have what it takes to increase earnings and deliver share performance over time.

Got $1,000? 3 Unstoppable Growth Stocks to Buy

Stryker

The healthcare industry is facing pent-up demand for surgeries. Health insurers may struggle with some additional costs as a result.

Elective Surgeries Are On the Rise: 3 Stocks That Can Benefit From This Trend

Lemonade

Intuitive Surgical is leveraging AI and machine learning to improve surgical outcomes. Lemonade's AI-based digital platform has simplified the purchasing of insurance policies.

2 AI Stocks to Buy Before They Skyrocket

Intuitive is the global market leader in robotic surgery -- and procedure volume is on the rise. Still, headwinds faced over the past year haven't disappeared.

Intuitive Surgical Stock: Bear vs. Bull

Intuitive Surgical is just getting started in the exciting robotic-assisted surgery market. Teladoc looks reasonably valued, given its prospects in the budding telehealth industry.

2 Growth Stocks to Buy and Hold for 10 Years

Boston Scientific

Centene

Elevance Health Inc

HCA Healthcare

Humana

Surgery Partners

Smith & Nephew

Tenet Healthcare

UnitedHealth Group

Zimmer Biomet Hlds

After a pandemic pause, hip and knee replacements are back. Long-postponed surgeries are being rescheduled, which is bad for business at insurance companies like UnitedHealth Group Inc. NYSE: UNH, but potentially good business for surgery centers like Surgery Partners Inc. NASDAQ: SGRY and companies like Zimmer Biomet Holdings Inc. NYSE: ZBH that manufacture joint-replacement technologies.

Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand

Alphabet

Intuitive Surgical has been growing steadily, and there's plenty more potential for it ahead. Alphabet's ability to adapt to changing trends and user preferences is key to its success.

2 Unstoppable Stocks to Buy and Hold for Decades

Tesla

Upstart Holdings

Artificial intelligence (AI) is estimated to have a $15.7 trillion impact on the global economy by 2030. Although tech stocks are the most logical beneficiary of the rise of AI, companies across a wide swath of sectors and industries are set to benefit.

3 Industry-Leading AI Stocks Outside the Tech Sector That Are on the Cutting Edge of Innovation

Doximity

Intuitive Surgical has been running higher on optimism that margins will rebound sooner than later. Doximity just shared its five-year goals, which could prove a profitable journey for shareholders.

2 Growing Healthcare Stocks to Own for the Long Term

Intuitive Surgical is positioned to continue growing steadily through 2033. It is actively improving its robotic surgical tools and expanding sales.

Where Will Intuitive Surgical Be in 10 Years?

Intuitive Surgical shares slid more than 25% last year. The company has faced headwinds including rising costs and unfavorable currency exchanges.

Intuitive Surgical: Buy, Sell, or Hold?

After its recent doldrums, Intuitive Surgical's business is now resurging. Its business model and general plans for the future haven't changed.

News for Intuitive Surgical Stock (ISRG)